Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.4M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
-4.71M
-
Total reported value, excl. options
-
$12.4M
-
Value change
-
-$2.28M
-
Number of buys
-
13
-
Number of sells
-
-32
-
Price
-
$0.39
Significant Holders of P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) as of Q3 2024
64 filings reported holding PIII - P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share as of Q3 2024.
P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
.
Largest 10 shareholders include Alyeska Investment Group, L.P. (15.7M shares), ARMISTICE CAPITAL, LLC (6.65M shares), MORGAN STANLEY (1.91M shares), VANGUARD GROUP INC (1.82M shares), Corient Private Wealth LLC (1.73M shares), GEODE CAPITAL MANAGEMENT, LLC (1.03M shares), MILLENNIUM MANAGEMENT LLC (486K shares), RENAISSANCE TECHNOLOGIES LLC (485K shares), Abundance Wealth Counselors (400K shares), and BlackRock, Inc. (382K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.